These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29384656)

  • 1. Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer's Disease.
    Więckowska A; Wichur T; Godyń J; Bucki A; Marcinkowska M; Siwek A; Więckowski K; Zaręba P; Knez D; Głuch-Lutwin M; Kazek G; Latacz G; Mika K; Kołaczkowski M; Korabecny J; Soukup O; Benkova M; Kieć-Kononowicz K; Gobec S; Malawska B
    ACS Chem Neurosci; 2018 May; 9(5):1195-1214. PubMed ID: 29384656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Ligands Targeting Cholinesterases and β-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore.
    Szałaj N; Bajda M; Dudek K; Brus B; Gobec S; Malawska B
    Arch Pharm (Weinheim); 2015 Aug; 348(8):556-63. PubMed ID: 26032855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents.
    Panek D; Więckowska A; Jończyk J; Godyń J; Bajda M; Wichur T; Pasieka A; Knez D; Pišlar A; Korabecny J; Soukup O; Sepsova V; Sabaté R; Kos J; Gobec S; Malawska B
    ACS Chem Neurosci; 2018 May; 9(5):1074-1094. PubMed ID: 29345897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT
    Więckowska A; Kołaczkowski M; Bucki A; Godyń J; Marcinkowska M; Więckowski K; Zaręba P; Siwek A; Kazek G; Głuch-Lutwin M; Mierzejewski P; Bienkowski P; Sienkiewicz-Jarosz H; Knez D; Wichur T; Gobec S; Malawska B
    Eur J Med Chem; 2016 Nov; 124():63-81. PubMed ID: 27560283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease.
    Zaręba P; Łątka K; Mazur G; Gryzło B; Pasieka A; Godyń J; Panek D; Skrzypczak-Wiercioch A; Höfner GC; Latacz G; Maj M; Espargaró A; Sabaté R; Jóźwiak K; Wanner KT; Sałat K; Malawska B; Kulig K; Bajda M
    Eur J Med Chem; 2023 Dec; 261():115832. PubMed ID: 37837674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT
    Wichur T; Pasieka A; Godyń J; Panek D; Góral I; Latacz G; Honkisz-Orzechowska E; Bucki A; Siwek A; Głuch-Lutwin M; Knez D; Brazzolotto X; Gobec S; Kołaczkowski M; Sabate R; Malawska B; Więckowska A
    Eur J Med Chem; 2021 Dec; 225():113783. PubMed ID: 34461507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
    Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
    ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
    Ma F; Du H
    Eur J Med Chem; 2017 Nov; 140():118-127. PubMed ID: 28923380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidirectional
    Szałaj N; Godyń J; Jończyk J; Pasieka A; Panek D; Wichur T; Więckowski K; Zaręba P; Bajda M; Pislar A; Malawska B; Sabate R; Więckowska A
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1944-1952. PubMed ID: 33092411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin 5-HT
    Więckowski K; Szałaj N; Gryzło B; Wichur T; Góral I; Sługocka E; Sniecikowska J; Latacz G; Siwek A; Godyń J; Bucki A; Kołaczkowski M; Więckowska A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta.
    Hebda M; Bajda M; Więckowska A; Szałaj N; Pasieka A; Panek D; Godyń J; Wichur T; Knez D; Gobec S; Malawska B
    Molecules; 2016 Mar; 21(4):410. PubMed ID: 27023510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin.
    Wang J; Wang ZM; Li XM; Li F; Wu JJ; Kong LY; Wang XB
    Bioorg Med Chem; 2016 Sep; 24(18):4324-4338. PubMed ID: 27460699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer's disease based on the fusion of donepezil and curcumin.
    Yan J; Hu J; Liu A; He L; Li X; Wei H
    Bioorg Med Chem; 2017 Jun; 25(12):2946-2955. PubMed ID: 28454848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT
    Toublet FX; Lalut J; Hatat B; Lecoutey C; Davis A; Since M; Corvaisier S; Freret T; Sopková-de Oliveira Santos J; Claeysen S; Boulouard M; Dallemagne P; Rochais C
    Eur J Med Chem; 2021 Jan; 210():113059. PubMed ID: 33310288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer's disease.
    Pasieka A; Panek D; Zaręba P; Sługocka E; Gucwa N; Espargaró A; Latacz G; Khan N; Bucki A; Sabaté R; Więckowska A; Malawska B
    Bioorg Med Chem; 2023 Jun; 88-89():117333. PubMed ID: 37236021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of new multitarget histamine H
    Łażewska D; Bajda M; Kaleta M; Zaręba P; Doroz-Płonka A; Siwek A; Alachkar A; Mogilski S; Saad A; Kuder K; Olejarz-Maciej A; Godyń J; Stary D; Sudoł S; Więcek M; Latacz G; Walczak M; Handzlik J; Sadek B; Malawska B; Kieć-Kononowicz K
    Eur J Med Chem; 2020 Dec; 207():112743. PubMed ID: 32882609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
    Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease.
    Czarnecka K; Girek M; Maciejewska K; Skibiński R; Jończyk J; Bajda M; Kabziński J; Sołowiej P; Majsterek I; Szymański P
    J Enzyme Inhib Med Chem; 2017 Dec; 33(1):158-170. PubMed ID: 29210299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphenylalkoxyamine Derivatives-Histamine H
    Łażewska D; Zaręba P; Godyń J; Doroz-Płonka A; Frank A; Reiner-Link D; Bajda M; Stary D; Mogilski S; Olejarz-Maciej A; Kaleta M; Stark H; Malawska B; Kieć-Kononowicz K
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34208297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.